TY - JOUR
T1 - Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients
AU - Shirakawa, Ryosuke
AU - Yokota, Takashi
AU - Nakajima, Takayuki
AU - Takada, Shingo
AU - Yamane, Miwako
AU - Furihata, Takaaki
AU - Maekawa, Satoshi
AU - Nambu, Hideo
AU - Katayama, Takashi
AU - Fukushima, Arata
AU - Saito, Akimichi
AU - Ishimori, Naoki
AU - Dela, Flemming
AU - Kinugawa, Shintaro
AU - Anzai, Toshihisa
N1 - Funding Information:
This work was supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (15K09115 to T.Y. and JP17H04758 to S.T.), a grant from the Center of Innovation Program from the Japan Science and Technology Agency (JPMJCE1301 to T.Y.), and funds from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T.Y.), the Nakatomi Foundation (to T.Y. and S.T.), the Northern Advancement Center for Science & Technology (to S.T.), and the Kimura Memorial Heart Foundation Research Grant (to S.T.). We thank Mami Sato and Yuki Kimura for their technical assistance.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Systemic oxidative stress plays a key role in the development of chronic heart failure (CHF). We tested the hypothesis that mitochondrial reactive oxygen species (ROS) generation in circulating peripheral blood mononuclear cells (PBMCs) contributes to CHF progression. A total of 31 patients who had a history of hospital admission due to worsening HF were enrolled and grouped as having either mild CHF defined as New York Heart Association (NYHA) functional class I-II or moderate-to-severe CHF defined as NYHA functional class III. ROS levels in PBMC mitochondria were significantly increased in CHF patients with NYHA functional class III compared to those with NYHA functional class I-II, accompanied by impaired mitochondrial respiratory capacity in PBMCs. ROS generation in PBMC mitochondria was positively correlated with urinary 8-hydroxydeoxyguanosine, a systemic oxidative stress marker, in CHF patients. Importantly, mitochondrial ROS generation in PBMCs was directly correlated with plasma levels of B-type natriuretic peptide, a biomarker for severity of HF, and inversely correlated with peak oxygen uptake, a parameter of exercise capacity, in CHF patients. The study showed that ROS generation in PBMC mitochondria was higher in patients with advanced CHF, and it was associated with disease severity and exercise intolerance in CHF patients.
AB - Systemic oxidative stress plays a key role in the development of chronic heart failure (CHF). We tested the hypothesis that mitochondrial reactive oxygen species (ROS) generation in circulating peripheral blood mononuclear cells (PBMCs) contributes to CHF progression. A total of 31 patients who had a history of hospital admission due to worsening HF were enrolled and grouped as having either mild CHF defined as New York Heart Association (NYHA) functional class I-II or moderate-to-severe CHF defined as NYHA functional class III. ROS levels in PBMC mitochondria were significantly increased in CHF patients with NYHA functional class III compared to those with NYHA functional class I-II, accompanied by impaired mitochondrial respiratory capacity in PBMCs. ROS generation in PBMC mitochondria was positively correlated with urinary 8-hydroxydeoxyguanosine, a systemic oxidative stress marker, in CHF patients. Importantly, mitochondrial ROS generation in PBMCs was directly correlated with plasma levels of B-type natriuretic peptide, a biomarker for severity of HF, and inversely correlated with peak oxygen uptake, a parameter of exercise capacity, in CHF patients. The study showed that ROS generation in PBMC mitochondria was higher in patients with advanced CHF, and it was associated with disease severity and exercise intolerance in CHF patients.
UR - http://www.scopus.com/inward/record.url?scp=85073164165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073164165&partnerID=8YFLogxK
U2 - 10.1038/s41598-019-51298-3
DO - 10.1038/s41598-019-51298-3
M3 - Article
C2 - 31605012
AN - SCOPUS:85073164165
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 14709
ER -